Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical Trial
NCT07571837 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63
Last updated 2026-05-06
Summary
The main cause of endodontic disorders is microbial infection. From the infected pulp tissue, microorganisms can penetrate into the deeper layers of root dentine and propagate a periapical tissue through the apical foramen and lateral canals causing apical periodontitis. Apical periodontitis is an inflammatory condition affecting the periapical area of teeth with a global prevalence of 52% among individuals and 5% at tooth level. At the periapical region, microbes and their products encounter the host immune defense. Innate immune cells combat bacteria through phagocytosis and release anti-microbial substances, while adaptive immune cells initiate both cell-mediated and humoral immune responses. This immune activation also stimulates osteoclasts, leading to bone resorption and creating space for the inflammatory cells' infiltration . During periapical inflammation, immune cells migrate to the periapical area, where they release pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), along with anti-inflammatory cytokines like interleukin-10 (IL-10). These cytokines play crucial roles in modulating inflammation and tissue repair.
MicroRNAs (miRNAs) are evolutionarily conserved small (18-22 nucleotides) single-stranded, noncoding RNAs. It has been well acknowledged that miRNAs influence gene expression at the posttranscriptional level by targeting mRNA 3'-untranslated regions (3'-UTRs). Accumulating evidence has suggested that miRNA expression is related to the clinical and biological features of diverse diseases, and they can be potential biomarkers for diagnosis, treatment, and prognosis. miRNAs have revealed their critical roles in regulating various cellular functions, including proliferation, apoptosis, differentiation, metabolism, and tumorigenesis, by targeting specific mRNAs.
MiR-146a regulates innate immunity, inflammatory responses, and the antiviral pathway. Changes in miR-146a expression have been noted in many human diseases, including autoimmune disorders and cancers. In addition, miR-146a is an important biomarker of disease diagnosis, prevention, and treatment. It is a negative regulator of inflammatory responses by suppressing target gene expression. However, limited data is available regarding the functional role of miR-146a in modulating the inflammatory response of periapical tissues following root canal disinfection in endodontic retreatment cases.
Eliminating microorganisms is the primary objective of root canal therapy in order to create an environment as free of bacteria as possible. However, not all root canal treatments are completely successful, and in some cases, the infection persists leading to development of secondary apical periodontitis in previously treated teeth.
Disinfecting the root canal during retreatment is significantly more challenging due to the presence of persistent microorganisms that have settled in the root canal system. These microbes are often resistant to standard irrigations and antimicrobial agents leading to the formation of periradicular lesions. Such bacteria can survive for extended periods around the previously filled root canals. Sodium hypochlorite (NaOCl) is the most widely used irrigant in root canal therapy due to its strong antibacterial effect and its ability to dissolve organic substances. Effective canal cleaning is difficult to achieve without the use of NaOCl at a sufficiently high concentration. However, NaOCl has several drawbacks, including its cytotoxicity which can lead to tissue damage and patient symptoms. Additionally, its strong oxidizing nature negatively affects the mechanical properties of dentin such as microhardness and elastic modulus. NaOCl should be used with caution in endodontic procedures to prevent hypochlorite accidents.
Calcium hydroxide (Ca (OH)2) is the most widely utilized intracanal medication. It has the potential to dissolve tissue, acts as a physical barrier and generates hydroxyl ions, creating an extremely alkaline environment. It has been shown to be quite effective in the treatment of teeth with persistent periapical lesions. To provide optimal endodontic treatment, the root canal system should be thoroughly cleaned of soft-tissue debris, smear layer, and bacteria. Nanoparticles (NPs) have unique characteristics such as smaller sizes, increased surface area to volume ratio, and higher chemical reactivity and charge density leading to greater interaction with the environment and negatively charged bacterial cells, compared to their bulk counterparts. These advantages can be used to design highly anti-microbial agents with maximal therapeutic efficacy and minimal side effects.
Conditions
- Post-operative Pain
- Periapical Inflammation
Interventions
- DRUG
-
Calcium hydroxide paste
Calcium hydroxide paste (MetaBiomed, Chungcheongbuk-do, Korea)
- DRUG
-
Nano-calcium hydroxide paste
Nano-calcium hydroxide paste (Nanogate company, Cairo, Egypt),
- DRUG
-
Nanochitosan paste
Nanochitosan paste (Nanogate company, Cairo, Egypt)
Sponsors & Collaborators
-
Al-Azhar University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-01
- Primary Completion
- 2027-01-15
- Completion
- 2027-01-30
Countries
- Egypt
Study Locations
More Related Trials
-
Evaluation of Post-Operative Pain Following the Use of Nano-Calcium Hydroxide
NCT07057336 ·Status: COMPLETED ·Phase: NA
-
The Effect of Diclofenac Potassium Insitu Gel Vs Calcium Hydroxide as Intra-canal Medications on Post-operative Pain and Anti-bacterial Effect
NCT04622488 ·Status: UNKNOWN ·Phase: NA
-
Influence of Intra Canal Medications on Postoperative Flare-up in Endodontic Re-treatment Cases
NCT03064191 ·Status: UNKNOWN ·Phase: NA
-
Effect of Bromelain Versus Calcium Hydroxide as an Intracanal Medication on the Intensity of Postoperative Pain and Bacterial Load Reduction in Necrotic Single Rooted Lower Premolars
NCT05687760 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions
NCT07423663 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of Pain Relief and Bacterial Reduction After Using Calcium Hydroxide With Mesoporous Silica Nanoparticles as an Intracanal Medicament in Necrotic Mandibular Molars: A Randomized Controlled Clinical Trial
NCT07327996 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effectiveness of Asiaticoside as Intracanal Medication on Infectious/Inflammatory Contents in Teeth With Apical Periodontitis
NCT06566508 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Assessment of Postoperative Pain After Using Two Formulations of Calcium Hydroxide Intracanal Medication .
NCT05021809 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Nitrofurantoin and Calcium Hydroxide as Intracanal Medicaments in Alleviating Post-operative Pain
NCT04900571 ·Status: COMPLETED ·Phase: PHASE4
-
The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament
NCT06207253 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Influence of Calcium Hydroxide Chlorhexidine Combination vs. Calcium Hydroxide as an Intra Canal Medicaments in Retreatment Cases
NCT03209115 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp.
NCT05582421 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Probiotics, Double Antibiotic Paste, and Calcium Hydroxide on Postoperative Pain in Irreversible Pulpitis: A Randomized Trial
NCT07270159 ·Status: COMPLETED ·Phase: NA
-
Chitosan,Chitosan Nanoparticles,and Chlorhexidine Gluconate, as Intra Canal Medicaments in Primary Teeth
NCT03588351 ·Status: UNKNOWN ·Phase: NA
-
Effect of Calcium Silicate-Based Root Canal Medicament After Retreatment
NCT06779370 ·Status: COMPLETED ·Phase: NA
-
Assessment of Postoperative Pain After Using Various Intracanal Medication in Patients With Necrotic Pulp
NCT03692286 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Antibacterial Effect of Allium Sativum, Calcium Hydroxide and Their Combination in Infected Mature Teeth
NCT05050071 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical and Radiographic Evaluation of the Synergistic Effect of Nano Silver Particles and Calcium Hydroxide Versus Triple Antibiotic Paste as Antibacterial Agents for Lesion Sterilization and Tissue Repair (LSTR) in Necrotic Primary Molars
NCT05681221 ·Status: UNKNOWN ·Phase: NA
-
Resolution of Pain and Swelling After the Use of Neem Leaf Extract Compared to Chlorhexidine Gluconate as an Intracanal Irrigant During Pulpectomy
NCT02943759 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Chitosan Irrigation in Premolar Root Canal Therapy (Randomized Trial)
NCT07048028 ·Status: RECRUITING ·Phase: NA
-
Antibacterial Effect of Light-activated Calcium Silicate Versus Light-activated Calcium Hydroxide
NCT03214770 ·Status: UNKNOWN ·Phase: PHASE1
-
Assessment of Pain and Antibacterial Activity of Chitosan Versus Sodium Hypochlorite as Irrigant in Infected Canal
NCT03719261 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Comparing the Effect of Different Intracanal Dressing on Failed Root Canal Treated Cases on Periapical Healing
NCT06342830 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Simvastatin Versus Calcium Hydroxide Intracanal Medications on Post-operative Pain and Interleukin 6 and 8
NCT05525013 ·Status: COMPLETED ·Phase: NA
-
Comparing Two Medicines for Healing Jaw Bone Infections After Root Canal Treatment
NCT07239739 ·Status: NOT_YET_RECRUITING ·Phase: NA